Meng Xia
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 5
- Hepatology top 5%
- Molecular Biology top 5%
- RNA modifications and cancer 18
- Cancer-related gene regulation 9
- Epigenetics and DNA Methylation 9
- RNA Research and Splicing 9
- Molecular Biology Techniques and Applications 5
- Rheumatology top 5%
- Folate and B Vitamins Research 5
- Reproductive Medicine top 5%
- Co-authors
- Shelly C. LuHeping YangJosé M. MatoKomal RamaniAinhoa Iglesias–AraTony W.H. LiQinghua XuXun Ye
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Meng Xia
91 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 107
- Cancer Research 507
- Hepatology 158
- Molecular Biology 1.3k
- Rheumatology 239
- Reproductive Medicine 126
Countries citing papers authored by Meng Xia
This map shows the geographic impact of Meng Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Xia more than expected).
Fields of papers citing papers by Meng Xia
This network shows the impact of papers produced by Meng Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Xia. The network helps show where Meng Xia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meng Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 9 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 10 | |
| 10 | 2020 | 45 | |
| 11 | 2019 | 4 | |
| 12 | 2018 | 14 | |
| 13 | 2017 | 16 | |
| 14 | 2016 | 83 | |
| 15 | 2015 | 14 | |
| 16 | 2013 | 18 | |
| 17 | 2012 | 25 | |
| 18 | 2010 | 40 | |
| 19 | 2008 | 47 | |
| 20 | 2008 | 87 |
About Meng Xia
Meng Xia is a scholar working on Cancer Research, Reproductive Medicine and Oncology, having authored 93 papers that have together received 2.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (18 papers), Cancer-related molecular mechanisms research (11 papers), Cancer-related gene regulation (9 papers), Epigenetics and DNA Methylation (9 papers), RNA Research and Splicing (9 papers), Molecular Biology Techniques and Applications (5 papers), Folate and B Vitamins Research (5 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (507 citations), Hepatology (158 citations) and Molecular Biology (1.3k citations). Meng Xia has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Shelly C. Lu, Heping Yang, José M. Mato, Komal Ramani, Ainhoa Iglesias–Ara, Tony W.H. Li, Qinghua Xu, Xun Ye, Chaoyang Sun and Kwang Suk Ko. Their work appears in journals such as Oncotarget, Hepatology, PLoS ONE, Scientific Reports and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.